Targeting HER2 in Patient-Derived Xenograft Ovarian Cancer Models Sensitizes Tumors to Chemotherapy

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12414
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Neoantigens Retention in Patient Derived Xenograft Models Mediates Autologous T Cells Activation in Ovarian Cancer

OncoImmunology
OncologyAllergyImmunology
2019English

Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer According to Tumorigenicity in Patient-Derived Xenograft Models

Cancer Research and Treatment
Cancer ResearchOncology
2018English

Knockdown of Cathepsin�L Sensitizes Ovarian Cancer Cells to Chemotherapy

Oncology Letters
Cancer ResearchOncology
2016English

Patient-Derived Xenograft (PDX) Models in Basic and Translational Breast Cancer Research

Cancer and Metastasis Reviews
Cancer ResearchOncology
2016English

Multiregion Genomic Analysis of Serially Transplanted Patient-Derived Xenograft Tumors

Cancer Genomics and Proteomics
MedicineBiochemistryGeneticsMolecular BiologyCancer Research
2018English

ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status

Cancer Research
Cancer ResearchOncology
2013English

Gene Expression Differences Between Matched Pairs of Ovarian Cancer Patient Tumors and Patient-Derived Xenografts

Scientific Reports
Multidisciplinary
2019English

Bioengineered miRNA-1291 Prodrug Therapy in Pancreatic Cancer Cells and Patient-Derived Xenograft Mouse Models

Cancer Letters
Cancer ResearchOncology
2019English

Establishment of Lung Cancer Patient-Derived Xenograft Models and Primary Cell Lines for Lung Cancer Study

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy